Tiplimotide

DB12738InvestigationalProtein Based Therapies

Tiplimotide has been used in trials studying the treatment of Multiple Sclerosis.

Code names
NBI-5788

Resolves to

Compound
UNII6VN101530YCAS178823-49-9
Targets
P02686MBP

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Tiplimotide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In